Myhep LVIR 400/90mg (Sofosbuvir/Ledipasvir)

Introduction

Hepatitis C is a serious viral infection that affects the liver and can lead to chronic liver disease, cirrhosis, or liver cancer if left untreated. With modern medical advancements, treatment outcomes have improved significantly. Myhep LVIR 400/90mg is one such effective therapy used to treat Hepatitis C.

It is a fixed-dose combination of two antiviral medicines, Sofosbuvir (400 mg) and Ledipasvir (90 mg). Together, they help eliminate the Hepatitis C virus (HCV) from the body and increase the chances of a complete cure.

What is Myhep LVIR 400/90mg?

Myhep LVIR is a combination antiviral medication containing:

Sofosbuvir (400 mg)

Sofosbuvir is a nucleotide polymerase inhibitor that blocks the viral RNA polymerase enzyme required for replication of the Hepatitis C virus. This stops the virus from multiplying.

Ledipasvir (90 mg)

Ledipasvir is an NS5A inhibitor that targets a protein essential for viral replication and assembly. It prevents the virus from spreading within the liver.

Together, these medicines provide an effective and well-tolerated treatment for Hepatitis C.

How Does Myhep LVIR Work

Myhep LVIR works by targeting and blocking key proteins required for the Hepatitis C virus to grow and multiply.

Action of Sofosbuvir

Sofosbuvir inhibits the NS5B polymerase enzyme, which is necessary for viral replication. This prevents the virus from copying its genetic material.

Action of Ledipasvir

Ledipasvir blocks the NS5A protein, which plays a vital role in viral replication and assembly. This stops the virus from spreading to healthy liver cells.

Together, these drugs reduce the viral load in the body and help restore liver function. Most patients achieve sustained virologic response (SVR), meaning the virus becomes undetectable after treatment.

Indications for Myhep LVIR 400/90mg

Chronic Hepatitis C Genotype 1

Highly effective for treating genotype 1, the most common type of Hepatitis C.

Chronic Hepatitis C Genotypes 4, 5, and 6

Also used for these genotypes depending on the patient’s condition and medical evaluation.

HIV and Hepatitis C Co-infection

Can be used in patients who have both HIV and Hepatitis C, with proper medical supervision.

Dosage and Administration

Standard Dosage

• One tablet daily (400 mg Sofosbuvir + 90 mg Ledipasvir)
• Taken with or without food

Instructions for Use

• Take the tablet at the same time every day
• Swallow whole; do not crush or chew
• If a dose is missed, take it as soon as remembered unless it is close to the next dose
• Do not take a double dose

Treatment Duration

Usually 8 to 12 weeks, depending on the severity of the condition and liver health.

Benefits of Myhep LVIR 400/90mg

High Cure Rate

Offers a high success rate with most patients achieving sustained virologic response (SVR).

Fewer Side Effects

Generally well tolerated with mild and manageable side effects.

No Need for Ribavirin

Unlike older treatments, it does not usually require ribavirin, reducing the risk of serious side effects.

Short Treatment Duration

Treatment is completed within 8 to 12 weeks in most cases.

Suitable for Many Patients

Can be used in patients with mild to moderate liver damage and in those with HIV co-infection.

Side Effects of Myhep LVIR 400/90mg

Common Side Effects

• Fatigue
• Headache
• Nausea
• Diarrhea
• Insomnia

Serious Side Effects

• Severe allergic reactions (rash, swelling, breathing difficulty)
• Liver problems (yellowing of skin or eyes, dark urine)
• Unusual bleeding or swelling

Seek medical attention if serious symptoms occur.

Precautions and Warnings

Liver Conditions

Patients with severe liver disease or cirrhosis should use this medicine under strict medical supervision.

Drug Interactions

May interact with medicines used for HIV, heart conditions, or seizures. Inform your doctor about all medications you are taking.

Pregnancy and Breastfeeding

Use only if prescribed. Consult your doctor before use during pregnancy or breastfeeding.

Kidney Problems

Use cautiously in patients with kidney impairment. Not recommended in severe cases.

Conclusion

Myhep LVIR 400/90mg (Sofosbuvir/Ledipasvir) is a highly effective treatment for Hepatitis C, offering high cure rates with a shorter treatment duration and fewer side effects. It works by stopping the virus from multiplying and helping the body eliminate it completely.